Joint inspections with eight other regulators carried at six of Ranbaxy‘s laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
first published: May 9, 2016 03:18 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

